Floatz logo

Pentoxifylline

Pancreatitis

Mayo ClinicSmall moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Pancreatitis cohort.

Asset / SponsorPhaseRating
Etomidate
Cheju Halla General Hospital
Phase 4BB
Meperidine
Cheju Halla General Hospital
Phase 4BB
Midazolam
Cheju Halla General Hospital
Phase 4BB
Magnesium Metallicum
University Medicine Greifswald
Phase 3BB
Pancrelipase
Dartmouth-Hitchcock Medical Center
Phase 2B
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone
Assiut University
Phase 2CCC
Propofol
Assiut University
Phase 2CCC
Pantoprazole
Washington University School of Medicine
Phase 2CCC

Same molecule, other indications

Pentoxifylline is also rated in:

metabolic dysfunction-associated steatohepatitisActive
BBB
Indicative · Phase 4
76 / 100
View asset →
type 2 diabetes mellitusDormant
BB
Indicative · Phase 4
68 / 100
View asset →
peripheral neuropathyActive
BB
Indicative · Phase 2/3
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →